NVCR

NOVOCURE LTD

Healthcare | Small Cap

-$0.34

EPS Forecast

$169.5

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$0.34

Revenue Forecast:

$169.5

EPS Surprise Forecast:

$0.056

Revenue Surprise Forecast:

$2

Post-release price volatility - High

Post-release Overnight Move:

±9.5%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

73%

Probability of beating revenue consensus:

63%

Probability of beating both EPS & revs consensus:

52%

Probability of missing both EPS & revs consensus:

15%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-1

Beta (β)

Forward Looking Beta (β):

2.00

Earnings volatility

EPS standard deviation:

$0.22

Revenue standard deviation:

$12

As % of share price:

1.82% EXTREME UNCERTAINTY

As % of market cap:

0.90% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.06

Revenue 95th %ile:

$185

EPS 75th %ile:

-$0.27

Revenue 75th %ile:

$174

EPS 25th %ile:

-$0.41

Revenue 25th %ile:

$166

EPS 5th %ile:

-$0.60

Revenue 5th %ile:

$156

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

40% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

80% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$28

Bid-ask per Share:

$0.035